抗抑郁药和体重增加:证据和临床影响的最新情况
Lauren Moss1, Marci Laudenslager2, Kristine J Steffen3,4
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21224, USA.
Current obesity reports
|January 3, 2025
概括
抗抑郁药的使用可以增加抑郁症患者的体重增加和肥胖风险. 新的药物和生活方式干预可以帮助有效地管理体重变化和代谢风险.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 代谢健康 代谢健康
背景情况:
- 抑郁症与更高的代谢障碍和体重增加风险有关.
- 抗抑郁药治疗可能会进一步加剧这些风险.
- 了解个体对体重变化的敏感性至关重要.
研究的目的:
- 审查当前关于抗抑郁药诱导体重变化的研究.
- 探索减轻抑郁症患者体重增加和肥胖风险的临床策略.
主要方法:
- 对最近关于抗抑郁药使用和体重变化研究的文献综述.
- 对影响体重的遗传,生物和临床因素的分析.
- 对药理和行为干预措施的评估.
主要成果:
- 遗传和生物因素预测了个体对抗抑郁药物对体重的反应.
- 一些抗抑郁药物 (如布洛普里昂,弗洛克塞丁,盖皮龙) 显示出有效性,降低了代谢风险.
- 体重中性替代品,行为干预措施和抗肥胖药物 (例如甲胺,利拉格卢提德) 是可行的策略.
结论:
- 临床医生可以通过考虑体重中性药物和个性化干预来优化治疗.
- 了解药物机制和副作用概况的进展有助于临床决策.
- 结合药物治疗和生活方式改变的综合方法是管理抑郁症和代谢健康的关键.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
192
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
192
Antidepressant Drugs: Overview
356
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
356
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
299
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
299
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Depression: Overview
213
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
213
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37


